0.5753
price up icon0.05%   0.0003
after-market Handel nachbörslich: .58 0.0047 +0.82%
loading
Schlusskurs vom Vortag:
$0.575
Offen:
$0.59
24-Stunden-Volumen:
532.48K
Relative Volume:
0.60
Marktkapitalisierung:
$49.57M
Einnahmen:
$2.24M
Nettoeinkommen (Verlust:
$-136.67M
KGV:
-0.2512
EPS:
-2.29
Netto-Cashflow:
$-102.08M
1W Leistung:
-0.54%
1M Leistung:
-1.13%
6M Leistung:
-35.43%
1J Leistung:
-76.33%
1-Tages-Spanne:
Value
$0.5666
$0.595
1-Wochen-Bereich:
Value
$0.5656
$0.615
52-Wochen-Spanne:
Value
$0.3418
$2.55

Century Therapeutics Inc Stock (IPSC) Company Profile

Name
Firmenname
Century Therapeutics Inc
Name
Telefon
215-981-4000
Name
Adresse
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Name
Mitarbeiter
165
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
IPSC's Discussions on Twitter

Vergleichen Sie IPSC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IPSC
Century Therapeutics Inc
0.5753 49.83M 2.24M -136.67M -102.08M -2.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-08 Eingeleitet Rodman & Renshaw Buy
2023-08-28 Herabstufung JP Morgan Overweight → Neutral
2022-12-27 Eingeleitet Chardan Capital Markets Buy
2022-10-31 Eingeleitet Guggenheim Buy
2022-10-10 Eingeleitet Canaccord Genuity Buy
2022-05-23 Eingeleitet H.C. Wainwright Buy
2022-05-12 Eingeleitet William Blair Mkt Perform
2021-07-13 Eingeleitet BofA Securities Buy
2021-07-13 Eingeleitet JP Morgan Overweight
2021-07-13 Eingeleitet Piper Sandler Overweight
Alle ansehen

Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Century Therapeutics Inc. stockHigh-impact investment strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Century Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

Is Century Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Century Therapeutics Inc. stock priceConsistent double returns - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 19, 2025
pulisher
Jul 18, 2025

What institutions are buying Century Therapeutics Inc. stock nowFree Step-by-Step Investment Guide - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

University City biotech Century Therapeutics is cutting 72 jobs, about half its workforce - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

Why Century Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Watch - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com

Jul 15, 2025
pulisher
Jul 15, 2025

Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

How Century Therapeutics Inc. stock performs during market volatilityFree Stock Market Query - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Century Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Why OBIO stock attracts strong analyst attentionHigh Yield Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Company’s Banking Stock: Dissecting a 51.83% Quarterly Revenue Decline Amid Growth - investchronicle.com

Jul 10, 2025
pulisher
Jul 08, 2025

Century Therapeutics (NASDAQ:IPSC) Shares Down 0.9% – What’s Next? - Defense World

Jul 08, 2025
pulisher
Jul 07, 2025

CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com

Jul 07, 2025
pulisher
Jul 07, 2025

Century Therapeutics to reduce headcount by 51% - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Century Therapeutics Announces Major Workforce Reduction - TipRanks

Jul 07, 2025
pulisher
Jun 25, 2025

Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum - Nasdaq

Jun 25, 2025
pulisher
Jun 20, 2025

Head-To-Head Contrast: Quince Therapeutics (NASDAQ:QNCX) and Century Therapeutics (NASDAQ:IPSC) - Defense World

Jun 20, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds Annual Stockholder Meeting By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds Annual Stockholder Meeting - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 16, 2025
pulisher
Jun 14, 2025

66,797 Shares in Century Therapeutics, Inc. (NASDAQ:IPSC) Acquired by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Increases Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Century Therapeutics, Inc. (NASDAQ:IPSC) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Takes $52,000 Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Raises Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain - sharewise

Jun 06, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Purchases 173,849 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Grows Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 03, 2025

Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):